Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells

Considering that the stereochemistry of the C9–C10 alkenyl portion of natural 9- cis-RA, as the one of the olefinic moiety of the previously described isoxazole retinoid 4, seems of particular importance for their apoptotic activity, we prepared a novel class of TTNPB analogues bearing both the cis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2000-12, Vol.10 (23), p.2669-2673
Hauptverfasser: Simoni, Daniele, Roberti, Marinella, Paolo Invidiata, Francesco, Rondanin, Riccardo, Baruchello, Riccardo, Malagutti, Cinzia, Mazzali, Angelica, Rossi, Marcello, Grimaudo, Stefania, Dusonchet, Luisa, Meli, Maria, Raimondi, Maria Valeria, D'Alessandro, Natale, Tolomeo, Manlio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2673
container_issue 23
container_start_page 2669
container_title Bioorganic & medicinal chemistry letters
container_volume 10
creator Simoni, Daniele
Roberti, Marinella
Paolo Invidiata, Francesco
Rondanin, Riccardo
Baruchello, Riccardo
Malagutti, Cinzia
Mazzali, Angelica
Rossi, Marcello
Grimaudo, Stefania
Dusonchet, Luisa
Meli, Maria
Raimondi, Maria Valeria
D'Alessandro, Natale
Tolomeo, Manlio
description Considering that the stereochemistry of the C9–C10 alkenyl portion of natural 9- cis-RA, as the one of the olefinic moiety of the previously described isoxazole retinoid 4, seems of particular importance for their apoptotic activity, we prepared a novel class of TTNPB analogues bearing both the cis or trans configuration of the alkenyl portion. The compounds were evaluated in vitro for their cytotoxic and apoptotic activities. We discovered that the cis-TTNPB 9c possesses apoptotic activity comparable with that of the retinoid 4. Moreover, the amino arotinoid 16c showed potent apoptotic activity in HL60 promyelocytic leukemia cells. Interestingly, 16c proved to be a particularly potent apoptosis-inducing agent active in multidrug resistant (MDR) cell lines. Therefore, to the best of our knowledge, 16c may represent the first known aminoarotinoid endowed with potent apoptotic activity in MDR cells. Taken together, these results seem to point out that the cis-stilbene motif of arotinoids may be at least an important feature in conferring cytotoxic and apoptotic activity to this class of compounds.
doi_str_mv 10.1016/S0960-894X(00)00547-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72507783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X00005473</els_id><sourcerecordid>72507783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-97f0eedb06a08543b03025a2b68153814b5402057627af8a536b3086819fb01e3</originalsourceid><addsrcrecordid>eNqFkV2L1TAQhoso7nH1JygBQXYvqpM2aXO8ETl-woILKngX0nR6NtImNZMe2X_lTzTng_XSqwx5nzeZmbconnJ4yYE3r77CuoFSrcWPC4BLACnasr5XrLhoRFkLkPeL1R1yVjwi-gnABQjxsDjjnFeqEWpV_LmOYRvNNGHPLI4j69GkG3ZxvXl3yQxRsM6krP12-TbdIKPkxg49sikkN7AwMBNz5YPr6TXrHdmww3i7F3yuRmbmMKdAjpjz_WIxMrNFn4jNgQiJnN8yY5PbuZRdnk3LmFwfly2LmF3J-MTSMoV46I8eFw8GMxI-OZ3nxfcP779tPpVXXz5-3ry9Km2t1qlctwMg9h00BpQUdQc1VNJUXaO4rBUXnRRQgWybqjWDMrJuuhpUVtdDBxzr8-LF8d05hl8LUtJTni13YDyGhXRbSWhbVWdQHkEb80ARBz1HN5l4qznofVT6EJXe56AB9CEqvfc9O32wdHn7_1ynbDLw_AQYsmYcovHW0R2nQFZVk6k3RwrzMnYOoybr0FvsXUSbdB_cfxr5C1Oes5c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72507783</pqid></control><display><type>article</type><title>Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Simoni, Daniele ; Roberti, Marinella ; Paolo Invidiata, Francesco ; Rondanin, Riccardo ; Baruchello, Riccardo ; Malagutti, Cinzia ; Mazzali, Angelica ; Rossi, Marcello ; Grimaudo, Stefania ; Dusonchet, Luisa ; Meli, Maria ; Raimondi, Maria Valeria ; D'Alessandro, Natale ; Tolomeo, Manlio</creator><creatorcontrib>Simoni, Daniele ; Roberti, Marinella ; Paolo Invidiata, Francesco ; Rondanin, Riccardo ; Baruchello, Riccardo ; Malagutti, Cinzia ; Mazzali, Angelica ; Rossi, Marcello ; Grimaudo, Stefania ; Dusonchet, Luisa ; Meli, Maria ; Raimondi, Maria Valeria ; D'Alessandro, Natale ; Tolomeo, Manlio</creatorcontrib><description>Considering that the stereochemistry of the C9–C10 alkenyl portion of natural 9- cis-RA, as the one of the olefinic moiety of the previously described isoxazole retinoid 4, seems of particular importance for their apoptotic activity, we prepared a novel class of TTNPB analogues bearing both the cis or trans configuration of the alkenyl portion. The compounds were evaluated in vitro for their cytotoxic and apoptotic activities. We discovered that the cis-TTNPB 9c possesses apoptotic activity comparable with that of the retinoid 4. Moreover, the amino arotinoid 16c showed potent apoptotic activity in HL60 promyelocytic leukemia cells. Interestingly, 16c proved to be a particularly potent apoptosis-inducing agent active in multidrug resistant (MDR) cell lines. Therefore, to the best of our knowledge, 16c may represent the first known aminoarotinoid endowed with potent apoptotic activity in MDR cells. Taken together, these results seem to point out that the cis-stilbene motif of arotinoids may be at least an important feature in conferring cytotoxic and apoptotic activity to this class of compounds.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(00)00547-3</identifier><identifier>PMID: 11128648</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Biological and medical sciences ; Drug Resistance, Multiple ; General aspects ; HL-60 Cells ; Humans ; K562 Cells ; Medical sciences ; Pharmacology. Drug treatments ; Retinoids - chemistry ; Retinoids - pharmacology ; Stilbenes - pharmacology</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2000-12, Vol.10 (23), p.2669-2673</ispartof><rights>2000 Elsevier Science Ltd</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-97f0eedb06a08543b03025a2b68153814b5402057627af8a536b3086819fb01e3</citedby><cites>FETCH-LOGICAL-c389t-97f0eedb06a08543b03025a2b68153814b5402057627af8a536b3086819fb01e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X00005473$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=805226$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11128648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simoni, Daniele</creatorcontrib><creatorcontrib>Roberti, Marinella</creatorcontrib><creatorcontrib>Paolo Invidiata, Francesco</creatorcontrib><creatorcontrib>Rondanin, Riccardo</creatorcontrib><creatorcontrib>Baruchello, Riccardo</creatorcontrib><creatorcontrib>Malagutti, Cinzia</creatorcontrib><creatorcontrib>Mazzali, Angelica</creatorcontrib><creatorcontrib>Rossi, Marcello</creatorcontrib><creatorcontrib>Grimaudo, Stefania</creatorcontrib><creatorcontrib>Dusonchet, Luisa</creatorcontrib><creatorcontrib>Meli, Maria</creatorcontrib><creatorcontrib>Raimondi, Maria Valeria</creatorcontrib><creatorcontrib>D'Alessandro, Natale</creatorcontrib><creatorcontrib>Tolomeo, Manlio</creatorcontrib><title>Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Considering that the stereochemistry of the C9–C10 alkenyl portion of natural 9- cis-RA, as the one of the olefinic moiety of the previously described isoxazole retinoid 4, seems of particular importance for their apoptotic activity, we prepared a novel class of TTNPB analogues bearing both the cis or trans configuration of the alkenyl portion. The compounds were evaluated in vitro for their cytotoxic and apoptotic activities. We discovered that the cis-TTNPB 9c possesses apoptotic activity comparable with that of the retinoid 4. Moreover, the amino arotinoid 16c showed potent apoptotic activity in HL60 promyelocytic leukemia cells. Interestingly, 16c proved to be a particularly potent apoptosis-inducing agent active in multidrug resistant (MDR) cell lines. Therefore, to the best of our knowledge, 16c may represent the first known aminoarotinoid endowed with potent apoptotic activity in MDR cells. Taken together, these results seem to point out that the cis-stilbene motif of arotinoids may be at least an important feature in conferring cytotoxic and apoptotic activity to this class of compounds.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Drug Resistance, Multiple</subject><subject>General aspects</subject><subject>HL-60 Cells</subject><subject>Humans</subject><subject>K562 Cells</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Retinoids - chemistry</subject><subject>Retinoids - pharmacology</subject><subject>Stilbenes - pharmacology</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV2L1TAQhoso7nH1JygBQXYvqpM2aXO8ETl-woILKngX0nR6NtImNZMe2X_lTzTng_XSqwx5nzeZmbconnJ4yYE3r77CuoFSrcWPC4BLACnasr5XrLhoRFkLkPeL1R1yVjwi-gnABQjxsDjjnFeqEWpV_LmOYRvNNGHPLI4j69GkG3ZxvXl3yQxRsM6krP12-TbdIKPkxg49sikkN7AwMBNz5YPr6TXrHdmww3i7F3yuRmbmMKdAjpjz_WIxMrNFn4jNgQiJnN8yY5PbuZRdnk3LmFwfly2LmF3J-MTSMoV46I8eFw8GMxI-OZ3nxfcP779tPpVXXz5-3ry9Km2t1qlctwMg9h00BpQUdQc1VNJUXaO4rBUXnRRQgWybqjWDMrJuuhpUVtdDBxzr8-LF8d05hl8LUtJTni13YDyGhXRbSWhbVWdQHkEb80ARBz1HN5l4qznofVT6EJXe56AB9CEqvfc9O32wdHn7_1ynbDLw_AQYsmYcovHW0R2nQFZVk6k3RwrzMnYOoybr0FvsXUSbdB_cfxr5C1Oes5c</recordid><startdate>20001204</startdate><enddate>20001204</enddate><creator>Simoni, Daniele</creator><creator>Roberti, Marinella</creator><creator>Paolo Invidiata, Francesco</creator><creator>Rondanin, Riccardo</creator><creator>Baruchello, Riccardo</creator><creator>Malagutti, Cinzia</creator><creator>Mazzali, Angelica</creator><creator>Rossi, Marcello</creator><creator>Grimaudo, Stefania</creator><creator>Dusonchet, Luisa</creator><creator>Meli, Maria</creator><creator>Raimondi, Maria Valeria</creator><creator>D'Alessandro, Natale</creator><creator>Tolomeo, Manlio</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001204</creationdate><title>Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells</title><author>Simoni, Daniele ; Roberti, Marinella ; Paolo Invidiata, Francesco ; Rondanin, Riccardo ; Baruchello, Riccardo ; Malagutti, Cinzia ; Mazzali, Angelica ; Rossi, Marcello ; Grimaudo, Stefania ; Dusonchet, Luisa ; Meli, Maria ; Raimondi, Maria Valeria ; D'Alessandro, Natale ; Tolomeo, Manlio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-97f0eedb06a08543b03025a2b68153814b5402057627af8a536b3086819fb01e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Drug Resistance, Multiple</topic><topic>General aspects</topic><topic>HL-60 Cells</topic><topic>Humans</topic><topic>K562 Cells</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Retinoids - chemistry</topic><topic>Retinoids - pharmacology</topic><topic>Stilbenes - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simoni, Daniele</creatorcontrib><creatorcontrib>Roberti, Marinella</creatorcontrib><creatorcontrib>Paolo Invidiata, Francesco</creatorcontrib><creatorcontrib>Rondanin, Riccardo</creatorcontrib><creatorcontrib>Baruchello, Riccardo</creatorcontrib><creatorcontrib>Malagutti, Cinzia</creatorcontrib><creatorcontrib>Mazzali, Angelica</creatorcontrib><creatorcontrib>Rossi, Marcello</creatorcontrib><creatorcontrib>Grimaudo, Stefania</creatorcontrib><creatorcontrib>Dusonchet, Luisa</creatorcontrib><creatorcontrib>Meli, Maria</creatorcontrib><creatorcontrib>Raimondi, Maria Valeria</creatorcontrib><creatorcontrib>D'Alessandro, Natale</creatorcontrib><creatorcontrib>Tolomeo, Manlio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simoni, Daniele</au><au>Roberti, Marinella</au><au>Paolo Invidiata, Francesco</au><au>Rondanin, Riccardo</au><au>Baruchello, Riccardo</au><au>Malagutti, Cinzia</au><au>Mazzali, Angelica</au><au>Rossi, Marcello</au><au>Grimaudo, Stefania</au><au>Dusonchet, Luisa</au><au>Meli, Maria</au><au>Raimondi, Maria Valeria</au><au>D'Alessandro, Natale</au><au>Tolomeo, Manlio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2000-12-04</date><risdate>2000</risdate><volume>10</volume><issue>23</issue><spage>2669</spage><epage>2673</epage><pages>2669-2673</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Considering that the stereochemistry of the C9–C10 alkenyl portion of natural 9- cis-RA, as the one of the olefinic moiety of the previously described isoxazole retinoid 4, seems of particular importance for their apoptotic activity, we prepared a novel class of TTNPB analogues bearing both the cis or trans configuration of the alkenyl portion. The compounds were evaluated in vitro for their cytotoxic and apoptotic activities. We discovered that the cis-TTNPB 9c possesses apoptotic activity comparable with that of the retinoid 4. Moreover, the amino arotinoid 16c showed potent apoptotic activity in HL60 promyelocytic leukemia cells. Interestingly, 16c proved to be a particularly potent apoptosis-inducing agent active in multidrug resistant (MDR) cell lines. Therefore, to the best of our knowledge, 16c may represent the first known aminoarotinoid endowed with potent apoptotic activity in MDR cells. Taken together, these results seem to point out that the cis-stilbene motif of arotinoids may be at least an important feature in conferring cytotoxic and apoptotic activity to this class of compounds.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>11128648</pmid><doi>10.1016/S0960-894X(00)00547-3</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2000-12, Vol.10 (23), p.2669-2673
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_72507783
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Antineoplastic agents
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Apoptosis - drug effects
Biological and medical sciences
Drug Resistance, Multiple
General aspects
HL-60 Cells
Humans
K562 Cells
Medical sciences
Pharmacology. Drug treatments
Retinoids - chemistry
Retinoids - pharmacology
Stilbenes - pharmacology
title Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T18%3A45%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Programmed%20cell%20death%20(PCD)%20associated%20with%20the%20stilbene%20motif%20of%20arotinoids:%20discovery%20of%20novel%20apoptosis%20inducer%20agents%20possessing%20activity%20on%20multidrug%20resistant%20tumor%20cells&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Simoni,%20Daniele&rft.date=2000-12-04&rft.volume=10&rft.issue=23&rft.spage=2669&rft.epage=2673&rft.pages=2669-2673&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(00)00547-3&rft_dat=%3Cproquest_cross%3E72507783%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72507783&rft_id=info:pmid/11128648&rft_els_id=S0960894X00005473&rfr_iscdi=true